Scarica l'app Stockscreener
35.24
3.54%
1.205
Dopo l'orario di chiusura:
35.24
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$34.03
Aprire:
$34.66
Volume 24 ore:
144.19K
Relative Volume:
0.41
Capitalizzazione di mercato:
$1.43B
Reddito:
$1.50B
Utile/perdita netta:
$95.23M
Rapporto P/E:
15.14
EPS:
2.328
Flusso di cassa netto:
$12.77M
1 W Prestazione:
+6.63%
1M Prestazione:
+11.20%
6M Prestazione:
-10.83%
1 anno Prestazione:
+20.77%
Intervallo 1D:
$34.54
$35.37
Intervallo di 1 settimana:
$32.80
$35.37
Portata 52W:
$25.58
$60.08
Phibro Animal Health Corp Stock (PAHC) Company Profile
Nome
Phibro Animal Health Corp
Settore
Telefono
201-329-7300
Indirizzo
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
35.24 | 1.38B | 1.50B | 95.23M | 12.77M | 2.328 |
TAK
Takeda Pharmaceutical Co Adr
|
17.44 | 55.06B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.94 | 43.07B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.08 | 35.88B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.92 | 31.59B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
527.94 | 26.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Neutral |
| 2025-07-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-06-16 | Aggiornamento | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | Iniziato | JP Morgan | Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Underperform |
| 2022-12-21 | Iniziato | ROTH Capital | Buy |
| 2022-07-25 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Ripresa | Credit Suisse | Neutral |
| 2021-07-07 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Downgrade | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Reiterato | BofA/Merrill | Underperform |
| 2019-06-11 | Iniziato | Barclays | Underweight |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-05-09 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Ripresa | BofA/Merrill | Underperform |
| 2017-06-02 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Iniziato | Piper Jaffray | Overweight |
| 2016-11-11 | Downgrade | Macquarie | Neutral → Underperform |
| 2016-11-10 | Downgrade | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Reiterato | Guggenheim | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2016-01-15 | Downgrade | Barclays | Overweight → Underweight |
| 2015-09-30 | Iniziato | Gabelli & Co | Buy |
| 2015-04-24 | Reiterato | Barclays | Overweight |
| 2015-04-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Iniziato | Barclays | Overweight |
Mostra tutto
Phibro Animal Health Corp Borsa (PAHC) Ultime notizie
PAHC|Phibro Animal Health Corp|Price:34.035|Chg%:-0.005 - TradingKey
Phibro Animal Health Corp (PAHC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Phibro Animal Health Corp (PAHC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Phibro Animal Health Corp (PAHC) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
Phibro Animal Health Corp (PAHC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Phibro Animal Health Corporatio (PAHC) Stock Forecasts - Yahoo Finance
Phibro Animal Health Corp (PAHC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? - Yahoo Finance Australia
Phibro Animal Health Corp (PAHC) Shares Fall 3.5% -- GF Value Sa - GuruFocus
Q3 2026 Phibro Animal Health Corp Earnings Call Transcript - GuruFocus
Phibro Animal Health Corp at Bank of America Global Healthcare Conference Transcript - GuruFocus
Phibro Animal Health (PAHC) Stock Looks Reasonable On Value But Stretched After 138% Gain - Yahoo Finance
Phibro Animal Health (PAHC) Stock Loses Russell Index Spots And Investor Visibility - Yahoo Finance
Las ETF que invierten en acciones de Phibro Animal Health Corporation Class A - TradingView
MSN Money - MSN
Implied Volatility Surging for Phibro Animal Health Stock Options - Yahoo Finance
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo! Finance Canada
Phibro Q3 FY2026 slides: 10% sales growth amid regulatory headwinds - Investing.com
Phibro Animal Health CEO Jack Bendheim sells $1.02m in PAHC shares - Investing.com
Phibro (NASDAQ: PAHC) CEO receives 300,000 performance units award - Stock Titan
Q1 Rundown: Phibro Animal Health (NASDAQ:PAHC) Vs Other Branded Pharmaceuticals Stocks - Yahoo Finance
Wall Street Analysts Predict a 36.23% Upside in Phibro (PAHC): Here's What You Should Know - Yahoo! Finance Canada
Phibro Animal Health Corporation(NasdaqGM: PAHC) dropped from Russell 3000E Index - marketscreener.com
Phibro Animal Health Corporation(NasdaqGM: PAHC) dropped from Russell Microcap Index - marketscreener.com
Phibro Animal Health Corporation(NasdaqGM:PAHC) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Phibro Animal Health Corporation 8-K Filing June 2026: Key Details, Trading Symbol, and Company Information - Minichart
Daniel Bendheim named CEO and President of Phibro Animal Health - TradingView
New Phibro (NASDAQ: PAHC) CEO granted 300,000 performance-based RSUs - Stock Titan
Phibro Animal Health Corp (PAHC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Paws and profits: adoro Pet Insurance names chief business development officer and other updates - DVM360
PAHC News | PHIBRO ANIMAL HEALTH CORP-A (NASDAQ:PAHC) - ChartMill
PAHC - Finviz
Phibro Animal Health Corp (PAHC) Institutional Confidence - TradingKey
Phibro Animal Health Corp (PAHC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Phibro Animal Health Corp (PAHC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
What Makes Phibro (PAHC) a New Buy Stock - Yahoo Finance
[144] PHIBRO ANIMAL HEALTH CORP SEC Filing - Stock Titan
Should You Continue to Hold PAHC Stock in Your Portfolio? - Yahoo Finance
Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares? - Yahoo Finance
PAHC Stock: What's Driving Phibro's Animal Health Growth - Yahoo Finance
Is PAHC Undervalued at 10x Earnings vs Peers? - Yahoo Finance
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
Phibro Animal Health Corp (PAHC) Stock Price Today & Analysis - Gotrade
Phibro Animal Health (PAHC) Q3 2026 Earnings Call Transcript - MLQ.ai
How The Story Is Shifting For Phibro Animal Health (PAHC) As Analysts Reset Fair Value - Yahoo Finance
Phibro Animal Health Corp Azioni (PAHC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.30%
2.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):